Send us Feedback

Eisai Co. Ltd. (ESALY)
Analysis
SUMMARY
BULLS
BEARS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
UPDATE: Arena Pharma Issues Update on Upcoming US Launch of BELVIQ, to Get $65M Milestone Payment from Eisai
Benzinga  May 7  Comment 
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the Office of the Federal Register filed for public inspection the US Drug Enforcement Administration's (DEA) final rule placing BELVIQ ^ (pronounced BEL-VEEK) into Schedule IV of...
Japan's Eisai amps up in China with new manufacturing plant
FiercePharma  Apr 25  Comment 
Eisai is drawing a bigger target on China with plans for a new manufacturing plant near Suzhou. The Japanese drugmaker will use the plant to tap growing demand in that country, as well as an export base for other emerging markets in Asia. Report
GE Healthcare and Eisai to Partner on Alzheimer's Disease Research
Benzinga  Apr 24  Comment 
GE (NYSE: GE) Healthcare today announced a research collaboration agreement with Eisai Inc. for use of the GE Healthcare investigational PET amyloid imaging agent, [18F]flutemetamol, to help select patients for a phase I clinical trial being...
Top IT chief Perakslis steps down at FDA
FierceBiotech  Apr 12  Comment 
Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad) from your shop to Michael Gibney (email | Twitter) or Emily Mullin (email | Twitter) and we will feature it here each...
Eisai Announces Preclinical Research Findings Suggesting Novel Infibitory Effect on Tumor Metastasis for Anticancer Agent Halaven(R) at AACR 104th Annual Meeting
JCN Network  Apr 10  Comment 
Eisai Co., Ltd. announced today that it has presented preclinical research findings suggesting a potential inhibitory effect on tumor metastasis as a possible novel mechanism of action for anticancer agent Halaven(R) (eribulin mesylate,...
Eisai Co-establishes the Global Health Innovative Technology Fund
JCN Network  Apr 8  Comment 
Eisai Co., Ltd. has co-established the Global Health Innovative Technology Fund (GHIT Fund) to advance the research and development of new medicines, vaccines, and diagnostics from Japan to fight infectious diseases in emerging countries and the...
Eisai Establishes Pharma Sales Subsidiary in Moscow Ahead of Planned Direct Sales Launch in Russia
JCN Network  Apr 5  Comment 
Eisai Co., Ltd. announced today that it has established a new pharmaceutical sales subsidiary in Moscow, Russia, which will be named Limited Liability Company Eisai ("Eisai Russia"). Eisai Russia will function as a direct subsidiary of Eisai's...




more ▼WIKI ANALYSIS
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


You may also be interested in articles related to Eisai Co. Ltd. (ESALY):
 




References

Retrieved from "http://www.wikinvest.com/stock/Eisai_Co._Ltd._(ESALY)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki